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SUMMARY – The purpose of this study was to re-evaluate cut-off values used in screening for 
retinopathy of prematurity (ROP) in Croatia and to propose postnatal weight gain as an additional 
criterion, based on the Colorado Retinopathy of Prematurity prediction model. Medical records of 
267 premature infants from the Zagreb University Hospital Centre that underwent ROP screening 
between January 2009 and December 2010 were reviewed retrospectively. Collected data included 
gestational age, birth weight, sex, weekly weight measurements and fundus examination records. Re-
sults showed the cut-off values of gestational age (GA) and birth weight (BW) used in Croatia to be 
appropriate and postnatal weight gain in the first 28 days could be used as an additional criterion on 
screening in the following way: net weight gain in the first 28 days of ≤932 g for prediction of any 
form of ROP and of ≤660 g for prediction of severe ROP should be added to the existing criteria of 
GA (≤32 weeks) and/or BW (≤1500 g). Infants with a non-physiological postnatal weight gain are 
exception. This is the first Croatian study to propose postnatal weight gain as an additional criterion 
on ROP screening and requires further validation on a larger sample of Croatian infants.
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Introduction
Retinopathy of prematurity (ROP) is a vasoprolif-
erative disease of immature retina the consequences of 
which (low vision and blindness) can be avoided or at 
least reduced if well designed screening and timely 
treatment are applied1,2. Population at risk of ROP var-
ies greatly among countries depending on the level of 
socio-economic development3. Larger, more mature 
infants are developing severe ROP in countries with 
low/moderate levels of development compared with 
highly developed countries3,4. Hence, implementing 
high-income country guidelines into clinical practice 
of a middle-income country (such as Croatia) would 
result in missing infants with ROP, which is unaccept-
able considering the risk of potential lifetime blindness.
With advances in neonatal care, more preterm in-
fants survive, leading to an increased number of infants 
screened for ROP, especially in middle-income coun-
tries with highest ROP prevalence and wide range of 
preterm infants that develop ROP3-5. This burdens 
screening programs and subjects a large number of in-
fants to repeated, stressful and sometimes unnecessary 
examinations5-8. Therefore, new models for screening 
are being investigated in order to safely reduce the 
number of infants screened for ROP9-11. While the 
current screening criteria are based mainly on two pre-
natal risk factors, gestational age (GA) and birth 
weight (BW), recent research shows that poor postna-
tal weight gain is a good predictor of ROP10-15. Two 
major models incorporating postnatal weight gain 
(WINROP and CHOP-ROP) require serial longitu-
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dinal weekly weight gain calculations for an indeter-
minate number of weeks, which is demanding in a 
busy setting of neonatal unit16. In contrast, the latest 
algorithm, the Colorado Retinopathy of Prematurity 
model (CO-ROP) is a simple one-time application 
formula designed to identify infants at risk of any 
grade of ROP in a timely manner (4 weeks)17. The 
model assesses ROP through a combination of the fol-
lowing three criteria: GA ≤30 weeks, BW ≤1500 g, and 
net weight gain of ≤650 g between birth and 4 weeks 
of age. Both original17 and validation16,18 studies dem-
onstrated high sensitivity in predicting ROP, render-
ing CO-ROP a good tool for reducing the number of 
examinations.
Although ROP is a growing global public health 
problem, it is still insufficiently appreciated and ana-
lyzed in our country19. Current screening criteria used 
in Croatia are GA ≤32 weeks and/or BW ≤1500 g, or 
heavier and more mature infants with an unstable clin-
ical course who are at a high risk of ROP, as assessed 
by a neonatologist. For the reasons stated above, the 
CO-ROP criteria17 are not applicable in Croatia with-
out adjustment. The purpose of this study was there-
fore to perform a modification of the CO-ROP algo-
rithm and to assess its sensitivity and specificity in our 
birth cohort. More specifically, the goal was to set 
population-specific cut-off values of GA and BW in 
Croatia and to propose the postnatal weight gain as an 
important third component in assessing infants at risk 
of retinopathy.
Patients and Methods
This study was approved by the institutional Re-
view Board of the Zagreb University Hospital Centre 
and was conducted in accordance with the Helsinki 
Declaration. Medical records of 286 premature infants 
admitted to the neonatal intensive care unit at the Za-
greb University Hospital Centre that underwent ROP 
screening examinations between January 2009 and 
December 2010 were reviewed retrospectively.
Data collected included sex, GA, BW, weekly 
weight measurements (postnatal days 7, 14, 21 and 28) 
and fundus examination records (ROP stage, zone, 
presence of plus disease, any treatment required). ROP 
was graded using the International Classification of 
ROP20. Exclusion criteria were missing required data, 
lost to follow-up due to death or transfer to another 
facility, and non-physiological weight gain (hydro-
cephalus, anasarca). Nineteen patients met the exclu-
sion criteria and were therefore excluded from the 
study.
Dilated indirect fundus examinations were per-
formed starting at one month of age or GA 30 weeks 
(whichever was later) and continued at 1- or 2-week 
intervals based on the stage of disease and zone in-
volved. Patients with type 1 ROP according to the Ear-
ly Treatment for Retinopathy of Prematurity Trial2 
(ETROP) were treated with retinal laser photocoagula-
tion under general anesthesia. In case of inadequate 
treatment response, laser would be repeated and/or in-
travitreal bevacizumab applied for aggressive posterior 
ROP. Patients with type 2 ROP according to the 
ETROP criteria2 were under careful observation until 
progression into type 1 ROP or regression of the dis-
ease. For the purposes of this study, infants who devel-
oped type 1 or type 2 ROP were grouped as ‘severe’ 
ROP. All infants who developed ROP that did not meet 
type 1 or type 2 criteria were grouped as ‘mild’ ROP.
Statistical analysis
Quantitative data were analyzed using Kolmogo-
rov-Smirnov test and appropriate parametric statisti-
cal tests were used in further analysis. All quantitative 
data were expressed as arithmetic mean and standard 
deviation (SD), while categorical values were expressed 
as absolute number and corresponding share. One-way 
ANOVA was used to assess the significance of differ-
ences between the ROP groups. After the analysis of 
variance, post-hoc Bonferroni analysis was performed 
to assess the significance of relation between the study 
groups. Differences in categorical values were analyzed 
using χ2-test. ROC analysis determined the cut-off 
value of postnatal weight gain in 28 days that had 
100% sensitivity for detecting any form of ROP, as 
well as severe ROP. All p-values <0.05 were considered 
significant. IBM SPSS Statistics version 23 was used 
on all analyses.
Results
A total of 267 premature infants (146 females 
[54.7%]) were eligible for analysis. Demographic data 
of the included infants are shown in Table 1. The mean 
BW was 1375.8±394.1 g (range 620-2400 g) and 
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mean GA was 30.4±2.7 (range 23.4-37.4) weeks. Of 
these, 166 (62.2%) infants developed ROP, 75 (28.1%) 
developed severe ROP (type 1 or 2), and 101 (37.8%) 
did not develop any ROP. The mean GA of infants 
who developed ROP was 29.4±2.6 weeks, while their 
mean BW was 1243.2±341.9 g. Both GA and BW of 
infants who developed ROP was notably lower than 
that of healthy infants (p<0.001), with a wide range of 
both parameters, i.e. GA 23.4-35 weeks and BW 620-
2360 g. As expected, ROP incidence and severity were 
highest in lower BW and GA categories, as shown in 
Figures 1 and 2. On the other hand, 33.3% of infants 






















Postnatal weight gain at 28 days, g, 







Female, n (%) 45 (44.6) 51 (56.0) 50 (66.7) 0.014
ROP stage, n (%)     
1 - 32 (35.2) 3 (3.0)
<0.0012 - 57 (62.6) 10 (13.3)
3 - 2 (2.2) 62 (82.7)
ROP zone, n (%)
I - 0 (0.0) 25 (33.3)
<0.001II - 73 (80.2) 50 (66.6)
III - 18 (19.7) 0 (0.0)
Plus disease, n (%)     
No - 91 (100.0) 9 (12.0) <0.001Yes - 0 (0.0) 66 (88.0)
ROP = retinopathy of prematurity; SD = standard deviation; *one-way analysis of variance (ANOVA)
Fig. 1. Proportion of infants without retinopathy  
of prematurity (ROP), with mild and severe ROP,  
based on birth weight categories (χ2-test, p<0.001).
Fig. 2. Proportion of infants without retinopathy  
of prematurity (ROP), with mild and severe ROP,  
based on gestational age categories (χ2-test, p<0.001).
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with GA ≥32 weeks and 38.7% of infants with BW 
≥1500 g developed a certain degree of retinopathy, 
while 7.1% of infants with GA ≥32 weeks and 8.6% of 
infants with BW ≥1500 g developed a severe form of 
ROP.
Due to transfer of out-born infants into our ter-
tiary referral center or missing written data, there were 
102/1068 (9.6%) missing weekly weights; none of the 
infants had missing weight at 4 weeks (28 days) of age. 
Infants with severe ROP had a significantly lower net 
weight gain on postnatal day 28 (296.5±135.3; 
p<0.001) compared to infants with mild or no ROP 
(Table 1). Moreover, this difference was also evident 
on postnatal days 7, 14, and 21 (p<0.001). At one 
month of age, all infants that developed any ROP and 
severe ROP were in the net weight gain category of 
≤932 g and ≤660 g, respectively (Fig. 3). Therefore, 
these values were taken as cut-off values and added to 
the current national screening guidelines (GA ≤32 
weeks and/or BW ≤1500 g), as suggested in the CO-
ROP screening model17. The sensitivity, specificity, 
positive (PPV) and negative (NPV) predictive values, 
and the area under the ROC curve (AUC) of the main 
and secondary diagnostic criteria, and their combina-
tions in screening of infants for any form of ROP and 
severe ROP are presented in Tables 2 and 3.
Table 4 shows the number of infants detected us-
ing initial screening and screening based on net weight 
gain at one month of age (weight gain ≤932 g as a cut-
off value for any type of retinopathy and ≤660 g as a 
cut-off value for severe retinopathy). Using the net wet 
gain criterion reduced the number of infants screened 
by 10.1% for severe ROP and by 1.9% for any ROP 
compared to the current national guidelines alone.
Discussion
Our results showed the premature infants with a 
decreased net weight gain in the first 28 days of life to 
be at risk of developing retinopathy, regardless of GA 
and BW. Therefore, we present postnatal net weight 
gain as an additional biomarker in the ROP screening 
program, as proposed in the CO-ROP model17. CO-
ROP is a new and simple screening model for ROP 
based on GA, BW, and postnatal weight gain. It is an 
easy and fast procedure performed only once, on the 
28th day of a child’s life, which correlates with the time 
of initial fundus examination. However, the cut-off 
values established in a highly developed country such 
as the United States of America, where the model was 
developed and validated, cannot be applied to the Cro-
atian population where heavier and more mature in-
Fig. 3. Box and whisker plot of net weight gain (NWG) in the first 28 days 
with highlighted weight gain values for detection of any form of retinopathy  
of prematurity (ROP) and severe ROP (arithmetic mean is marked with ‘x’, 
other marks refer to medians, interquartile ranges, minimum and maximum 
ranges, and outliers).
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fants develop ROP. Therefore, this study analyzed cut-
off values of net weight gain in the first 28 days of life, 
which would include all infants at risk of ROP and the 
possibility to include this criterion into the existing 
national guidelines.
In developed countries, ROP occurs almost exclu-
sively among most premature infants and the inci-
dence of ROP is considerably lower than in develop-
ing countries such as Croatia5,19,21,22. On the other 
hand, in developing countries of Eastern Europe, Lat-
in America, India and China, the average BW and GA 
vary considerably, with very broad ranges4,5,23-25. The 
ranges of BW and GA in Croatia are similar to those 
in other developing countries, but they are very broad 
Table 2. Sensitivity, specificity, positive (PPV) and negative predictive value (NPV), and the area under the ROC 




Sensitivity Specificity PPV NPV AUC
N=101 N=166
n % n % % (95% CI) (95% CI) (95% CI) (95% CI)
GA ≤32 weeks
No 66 65.3% 33 19.9% 80.12% 65.00% 79.17% 66.33% 0.73








No 57 56.4% 36 21.7% 78.31% 56.44% 74.71% 61.29% 0.67







NWG at 28 days 
≤932 g No 5 5.0% 0 0.0% 100.00% 4.95% 63.36% 100.00% 0.52







GA ≤32 weeks 
and BW <1500 g No 76 75.2% 52 31.3% 68.67% 75.25% 82.01% 59.38% 0.72







GA ≤32 weeks 
and/or  
BW <1500 g
No 47 46.5% 17 10.2% 89.76% 46.53% 73.40% 73.44% 0.68







GA ≤32 weeks, 
BW <1500 g and 
NWG at 28 days 
≤932 g
No 77 76.2% 56 33.7% 66.27% 76.24% 82.09% 57.89% 0.71







GA ≤32 weeks 
and/or  
BW <1500 g  
and/or NWG at 
28 days ≤932 g
No 7 6.9% 0 0.0% 100.00% 6.93% 63.85% 100.00% 0.53







ROP = retinopathy of prematurity; GA = gestational age; BW = birth weight; NWG = net weight gain in the first 28 days; 95% CI = 95% 
confidence interval
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and differ significantly among regions, and even with-
in a single city3,5,19,26,27.
Postnatal net weight gain at one month was sig-
nificantly higher in our study (932 g and 660 g) than 
in the CO-ROP study (650 g and 400 g)17 for any 
form of ROP, as well as for severe ROP, which was 
expected due to the specificity of our population. We 
also analyzed cut-off values for the combination of 
GA, BW and net weight gain in the first 28 days as the 
criteria for inclusion in the ROP screening program 
(Tables 2 and 3). The sensitivity of <90% with the cur-
rent criteria (GA ≤32 weeks and/or BW ≤1500 g) 
highlights the immense role of neonatologist in the 
evaluation process. Only net weight gain ≤932 g for 
Table 3. Sensitivity, specificity, positive (PPV) and negative predictive value (NPV), and the area under the ROC 




Sensitivity Specificity PPV NPV AUC
N=101 N=166
n % n % % (95% CI) (95% CI) (95% CI) (95% CI)
GA ≤32 weeks
No 66 65.3% 7 9.3% 90.67% 65.35% 66.02% 90.41% 0.78








No 57 56.4% 8 10.7% 89.33% 56.44% 60.36% 87.69% 0.73







NWG in the first 
28 days ≤660 g No 21 20.8% 0 0.0% 100% 20.79% 48.39% 100% 0.6







GA ≤32 weeks 
and BW <1500 g No 76 75.2% 12 16.0% 84.00% 75.25% 71.59% 86.36% 0.8







GA ≤32 weeks 
and/or  
BW <1500 g
No 47 46.5% 3 4.0% 96.00% 46.53% 57.14% 94.00% 0.71







GA ≤32 weeks, 
BW <1500 g and 
NWG at 28 days 
≤660 g
No 79 78.2% 13 17.3% 82.67% 78.22% 73.81% 85.87% 0.8







GA ≤32 weeks 
and/or  
BW <1500 g  
and/or NWG at 
28 days ≤660 g
No 11 10.9% 0 0.0% 100% 10.89% 45.45% 100% 0.55







ROP = retinopathy of prematurity; GA = gestational age; BW = birth weight; NWG = net weight gain in the first 28 days; 95% CI = 95% 
confidence interval
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Table 4. Infants detected by initial screening and by using screening based on net weight gain  
in the first 28 days of life
Initial screening Screening for any form of ROP (≤932 g)
Screening for severe 
ROP (≤660 g)
Alarm No alarm Alarm No alarm Alarm No alarm
No ROP 101 0 96 5 80 21
Mild ROP 91 0 91 0 83 8
Severe ROP 75 0 75 0 75 0
Total 267 0 262 5 238 29
ROP = retinopathy of prematurity
any form of ROP and ≤660 g for severe ROP in the 
first 28 days was identified as an independent criterion 
with 100% sensitivity. Moreover, only the combination 
of GA ≤32 weeks and/or BW ≤1500 g and/or postna-
tal weight gain in 28 days of ≤932 g showed 100% sen-
sitivity in predicting any form of ROP. Similarly, only 
the combination of GA ≤32 weeks and/or BW ≤1500 
g and/or postnatal weight gain in 28 days of ≤660 g 
showed 100% sensitivity in predicting severe ROP. As 
far as specificity is concerned, using all three criteria 
was most specific (76.23% for any form of ROP and 
78.22% for severe ROP). Still, more than 20% of in-
fants would pass unscreened, which is unacceptable. 
Furthermore, if only the criterion of net weight gain in 
28 days had been used for ROP screening in our study, 
the number of examined children would have de-
creased by only 2%, which is significantly less than the 
figure reported for the CO-ROP16-18 (~23%) or WIN-
ROP (~75%) algorithm28. The reason for this low per-
centage was the generally higher prevalence of any 
form of ROP in our cohort.
In conclusion, in order not to miss a single child 
with ROP, the existing national guidelines are popula-
tion-specific and appropriately high given the impor-
tant role of neonatologist in assessing infants older 
than 32 weeks and heavier than 1500 g. However, pre-
mature infants with a decreased net weight gain in the 
first 28 days of life are at risk of developing retinopathy, 
regardless of GA and BW. Therefore, our study pro-
posed net weight gain in the first 28 days as an addi-
tional tool in the existing screening program, in the 
following way: the criterion of net weight gain of ≤932 
g in the first 28 days for prediction of any form of ROP 
and net weight gain of ≤660 g in the first 28 days for 
severe ROP should be added to the existing cut-off val-
ues of GA (≤32 weeks) and/or BW (≤1500 g). It is im-
portant to stress that infants with a non-physiological 
postnatal weight gain (edema, anasarca, hydrocephalus) 
are exception and need assessment by a neonatologist 
(out of 8 infants excluded from the study due to hydro-
cephalus, 4 developed type 1 ROP requiring treat-
ment). ROP research in Croatia is still very scarce and 
this study is the first Croatian study to propose net 
weight gain as an additional criterion in the screening 
model. However, further analysis on a larger sample of 
Croatian infants, at the national level, should be con-
ducted before considering implementation of postnatal 
weight gain into the existing screening criteria.
This study had some limitations, i.e. small sample 
size from a single tertiary hospital with high ROP-risk 
profile and incomplete data on net weight gain before 
postnatal day 28. Also, infants with a non-physiologi-
cal postnatal weight gain (edema, anasarca, hydro-
cephalus) could be evaluated with this algorithm and 
were excluded from the study. Nevertheless, the 
strengths of our study are several. Firstly, it was the 
first study in Croatia to propose net weight gain as an 
additional criterion in ROP screening; it was conduct-
ed on a European Caucasian population and can 
therefore be used in a wide range of comparisons, at 
the European and global level. Secondly, the study was 
performed in a developing country that can be further 
characterized as a transition country, and such indica-
tions on how to improve the Croatian health system 
are noteworthy. Moreover, our modification of the 
CO-ROP model serves as an example of how each in-
stitution and country can develop its population-spe-
cific criteria, which would ensure that all infants at risk 
of ROP are examined. Longitudinal follow-up and 
adjustment of the screening criteria according to the 
growth and development patterns of population, to-
gether with the research of other potential risk factors 
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would then most definitely lead to better neonatal care 
system, especially for developing countries such as 
Croatia.
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Sažetak
SLAB POSTNATALNI PORAST TJELESNE MASE  
KAO PREDIKTOR RETINOPATIJE NEDONOŠČADI
I. Behin Šarić, M-J. Šarić i N. Vukojević
Svrha ovoga istraživanja bila je procijeniti granične vrijednosti koje se koriste u probiru na retinopatiju nedonoščadi 
(ROP) u Hrvatskoj te predložiti postnatalni porast tjelesne mase kao dodatni kriterij, po uzoru na algoritam Colorado Reti-
nopathy of Prematurity (CO-ROP). Retrospektivno su analizirani podaci 267 nedonoščadi praćene u sklopu programa pro-
bira na ROP u Kliničkom bolničkom centru Zagreb od siječnja 2009. do prosinca 2010. godine. Prikupljeni podaci uključi-
vali su gestacijsku dob (GD), porođajnu masu (PM), spol, tjedna mjerenja tjelesne mase i praćenja nalaza na očnoj pozadini. 
Rezultati studije pokazali su da su granične vrijednosti za gestacijsku dob i porođajnu masu koje se koriste u Hrvatskoj pri-
mjerene za ovu populaciju te da postnatalni porast tjelesne mase u prvih 28 dana može poslužiti u programu probira na ROP 
na sljedeći način: uz postojeće kriterije, GD ≤32 tjedna i/ili PM ≤1500 g, dodati kriterij i/ili postnatalni porast tjelesne mase 
u 28 dana ≤932 g za predikciju bilo kojeg oblika ROP-a odnosno ≤660 g za predikciju teškog oblika ROP-a. Iznimka su 
djeca s nefiziološkim porastom tjelesne mase. Ovo istraživanje je prva hrvatska studija koja predlaže postnatalni porast tje-
lesne mase kao dodatni kriterij u programu probira na ROP i zahtijeva dodatna ispitivanja na većem uzorku hrvatske nedo-
noščadi.
Ključne riječi: Retinopatija nedonoščadi; Postnatalni porast tjelesne mase; Porođajna masa; Gestacijska dob; CO-ROP algori-
tam; Hrvatska
